Rosa’s appointment, made yesterday, makes him the second Intuitive executive to hold a seat on the company board, after CEO Gary Guthart.
The surgical robotics pioneer — the dominant company in the space — promoted Rosa into the president role last year. Rosa is a 27-year veteran of the company who has held leadership positions across multiple functions, including product development, commercial operations, and clinical and regulatory affairs. He presently in charge of the company’s business unit, quality, regulatory, manufacturing, and commercial operations. In addition, he is board chair of Intuitive-Fosun, the joint venture between Intuitive and Shanghai-based Fosun Pharma.
“Intuitive’s board leadership will benefit from Dave Rosa’s deep and broad experience across the company, as well as his commitment to excellence in operations, innovation, and customer collaboration,” Guthart said in a news release. “Balancing strategy and operations on the Board of Directors adds an important dimension to Intuitive stewardship.”
Rosa’s appointment came as the company expanded its board seats to 12 from the previous 11.
From what it means to persevere to the development of surgical robotics, Rosa had advice to share during a keynote interview at our DeviceTalks West event in Santa Clara, California, in October 2023. The next DeviceTalks West is coming up this October. Register here.
